ASX Announcements

Neuren's Rett syndrome Phase 2 trial published in Neurology
Fundamentals strong as Neuren advances neuroscience pipeline
Preliminary Final Report and statutory accounts
NNZ-2591 positive effects in Phelan-McDermid syndrome model
Plans for Phase 3 trial in Rett syndrome
Neuren retains ex-North America, appoints investment bank
Appendix 4C - quarterly
Final Director's Interest Notice
Ceasing to be a substantial holder
2018 Year-end Business Update

Pages:
1 2 3 4 5 6 7 8 9 10 ... Next